Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice
Open accessThe DOI matches its Crossref record; 75 of the 76 references it cites were found in a registry or an index.
Abstract
The tumor necrosis factor type 1 death receptor (TNFR1) contributes to apoptosis. TNFR1, a subgroup of the TNFR superfamily, contains a cytoplasmic death domain. We recently demonstrated that the TNFR1 cascade is required for amyloid β protein (Aβ)–induced neuronal death. However, the function of TNFR1 in Aβ plaque pathology and amyloid precursor protein (APP) processing in Alzheimer's disease (AD) remains unclear. We report that the deletion of the TNFR1 gene in APP23 transgenic mice (APP23/TNFR1−/−) inhibits Aβ generation and diminishes Aβ plaque formation in the brain. Genetic deletion of TNFR1 leads to reduced β-secretase 1 (BACE1) levels and activity. TNFR1 regulates BACE1 promoter activity via the nuclear factor-κB pathway, and the deletion of TNFR1 in APP23 transgenic mice prevents learning and memory deficits. These findings suggest that TNFR1 not only contributes to neurodegeneration but also that it is involved in APP processing and Aβ plaque formation. Thus, TNFR1 is a novel therapeutic target for AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several lines of evidence had linked the inhibition of TNF-α signaling with reduction of both Aβ and tau pathologies in vivo36,37.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [36]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866 · cited 1×
“The receptorinduced multimerization of a Fas-associated death domain protein leads to caspase activation, which causes degradation of specifi c target proteins, ultimately damaging cell integrity (Ashkenazi and Dixit, 1998).”
BackgroundVassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876
Alzheimer Disease in the US Population: Prevalence Estimates Using the 2000 Census
Hebert, L. E., Scherr, P. A., Bienias, J. L., Bennett, D. A., & Evans, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.8.1119 · Cited by 2,168
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective
Tanzi, R. E., & Bertram, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.008 · Cited by 1,849
Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D., & Gabbiani, G. (1986) · The Journal of cell biology · doi:10.1083/jcb.103.6.2787 · Cited by 1,621
Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · cited 1×
“This might be because the APP transgene is controlled by different promoters in APP23 and Tg2576 mice (Irizarry et al., 1997; Sturchler-Pierrat et al., 1997).”
BackgroundSelf-citationFarris, W., Mansourian, S., Chang, Y., Lindsley, L., Eckman, E. A., Frosch, M. P., Eckman, C. B., Tanzi, R. E., Selkoe, D. J., & Guénette, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0230450100 · Cited by 1,286
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Cerebral amyloid angiopathy. A critical review.
Vinters, H. V. (1987) · Stroke · doi:10.1161/01.str.18.2.311 · Cited by 1,071
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054
Bruce, A. J., Boling, W., Kindy, M. S., Peschon, J., Kraemer, P. J., Carpenter, M. K., Holtsberg, F. W., & Mattson, M. P. (1996) · Nature Medicine · doi:10.1038/nm0796-788 · Cited by 932
Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease model
Dodart, J.-C., Bales, K. R., Gannon, K. S., Greene, S. J., DeMattos, R. B., Mathis, C., DeLong, C. A., Wu, S., Wu, X., Holtzman, D. M., et al. (2002) · Nature Neuroscience · doi:10.1038/nn842 · Cited by 858
Elevated β-secretase expression and enzymatic activity detected in sporadic Alzheimer disease
Yang, L.-B., Lindholm, K., Yan, R., Citron, M., Xia, W., Yang, X.-L., Beach, T., Sue, L., Wong, P., Price, D., et al. (2003) · Nature Medicine · doi:10.1038/nm0103-3 · Cited by 729 · cited 5×
“We fi rst used an MCA-labeled BACE1 substrate (Yang et al., 2003; Li et al., 2004a) to examine BACE1 activity and found that BACE1 activity was significantly decreased in APP23/TNFR1−/− mice (Fig.”
BackgroundMethodInfluentialSelf-citationTNF Receptor-Deficient Mice Reveal Divergent Roles for p55 and p75 in Several Models of Inflammation
Peschon, J. J., Torrance, D. S., Stocking, K. L., Glaccum, M. B., Otten, C., Willis, C. R., Charrier, K., Morrissey, P. J., Ware, C. B., & Mohler, K. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.943 · Cited by 706
Weller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679
IRIZARRY, M. C., MCNAMARA, M., FEDORCHAK, K., HSIAO, K., & HYMAN, B. T. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199709000-00002 · Cited by 649 · cited 1×
“This might be because the APP transgene is controlled by different promoters in APP23 and Tg2576 mice (Irizarry et al., 1997; Sturchler-Pierrat et al., 1997).”
BackgroundBarger, S. W., Hörster, D., Furukawa, K., Goodman, Y., Krieglstein, J., & Mattson, M. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9328 · Cited by 631 · cited 1×
“Moreover, Barger et al. (1995) showed that TNFα can protect neurons derived from fetal brains against Aβ toxicity.”
BackgroundHsiao, K. K., Borchelt, D. R., Olson, K., Johannsdottir, R., Kitt, C., Yunis, W., Xu, S., Eckman, C., Younkin, S., Price, D., et al. (1995) · Neuron · doi:10.1016/0896-6273(95)90107-8 · Cited by 523 · cited 2×
“However, Irizarry et al. (1997) did not observe neuronal loss in 16-mo-old APP transgenic mice (Tg2576) expressing the APPK670N/M671L mutation, the same mutation harbored by APP23 mice.”
BackgroundNeuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502 · cited 2×
“Results were similar in the hippocampus, where APP23 mice had 15% fewer NeuN-positive cells in the CA1 area of the hippocampus (Fig. 9 B, D; Calhoun et al., 1998), whereas little neuronal loss was seen in APP23/TNFR1−/− mice at 24 mo of age (Fig.”
BackgroundResultSelf-citationIntrathecal inflammation precedes development of Alzheimer's disease
Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501
Li, R., Lindholm, K., Yang, L.-B., Yue, X., Citron, M., Yan, R., Beach, T., Sue, L., Sabbagh, M., Cai, H., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0205689101 · Cited by 496
Self-citationYan, Q., Zhang, J., Liu, H., Babu-Khan, S., Vassar, R., Biere, A. L., Citron, M., & Landreth, G. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-20-07504.2003 · Cited by 469
Pittenger, C., Huang, Y. Y., Paletzki, R. F., Bourtchouladze, R., Scanlin, H., Vronskaya, S., & Kandel, E. R. (2002) · Neuron · doi:10.1016/s0896-6273(02)00684-0 · Cited by 465 · cited 1×
“Mice will spend more time exploring a novel object than a familiar one (Pittenger et al., 2002; Bourtchouladze et al., 2003; Wang et al., 2004).”
BackgroundCalhoun, M. E., Burgermeister, P., Phinney, A. L., Stalder, M., Tolnay, M., Wiederhold, K.-H., Abramowski, D., Sturchler-Pierrat, C., Sommer, B., Staufenbiel, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.14088 · Cited by 410
Self-citationCongo red and protein aggregation in neurodegenerative diseases
Frid, P., Anisimov, S. V., & Popovic, N. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.08.001 · Cited by 402
Casas, C., Sergeant, N., Itier, J.-M., Blanchard, V., Wirths, O., van der Kolk, N., Vingtdeux, V., van de Steeg, E., Ret, G., Canton, T., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63388-3 · Cited by 400 · cited 1×
“The total number of neurons were obtained using unbiased stereology (Casas et al., 2004; Schmitz et al., 2004) and a microscope equipped with a digital camera (DEI-470; Optronics).”
MethodBoldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H., & Wallach, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.1.387 · Cited by 387 · cited 1×
“TNFR-associated death domain protein and/or a Fas-associated death domain protein/mediator of receptor-induced toxicity, two intracellular adaptor proteins (Boldin et al., 1995).”
BackgroundOxidative stress increases expression and activity of BACE in NT2 neurons
Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0515 · Cited by 385 · cited 1×
“BACE1 expression (Tamagno et al., 2002; Hong et al., 2003; Pak et al., 2005; Tamagno et al., 2005; Sastre et al., 2006).”
Thal, D. R., Ghebremedhin, E., Orantes, M., & Wiestler, O. D. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.12.1287 · Cited by 384
Sastre, M., Dewachter, I., Rossner, S., Bogdanovic, N., Rosen, E., Borghgraef, P., Evert, B. O., Dumitrescu-Ozimek, L., Thal, D. R., Landreth, G., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503839103 · Cited by 373
Tumor necrosis factor's cytotoxic activity is signaled by the p55 TNF receptor
Tartaglia, L. A., Rothe, M., Hu, Y.-F., & Goeddel, D. V. (1993) · Cell · doi:10.1016/0092-8674(93)90222-c · Cited by 339
Tamagno, E., Parola, M., Bardini, P., Piccini, A., Borghi, R., Guglielmotto, M., Santoro, G., Davit, A., Danni, O., Smith, M. A., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02895.x · Cited by 324 · cited 1×
“BACE1 expression (Tamagno et al., 2002; Hong et al., 2003; Pak et al., 2005; Tamagno et al., 2005; Sastre et al., 2006).”
Patel, N. S., Paris, D., Mathura, V., Quadros, A. N., Crawford, F. C., & Mullan, M. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-9 · Cited by 319
Bourtchouladze, R., Lidge, R., Catapano, R., Stanley, J., Gossweiler, S., Romashko, D., Scott, R., & Tully, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834280100 · Cited by 312
Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease
Matsuoka, Y., Picciano, M., Malester, B., LaFrancois, J., Zehr, C., Daeschner, J. M., Olschowka, J. A., Fonseca, M. I., O’Banion, M. K., Tenner, A. J., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64085-0 · Cited by 303
Self-citationWilcock, D. M., Rojiani, A., Rosenthal, A., Levkowitz, G., Subbarao, S., Alamed, J., Wilson, D., Wilson, N., Freeman, M. J., Gordon, M. N., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1090-04.2004 · Cited by 299
Age‐dependent cognitive decline in the APP23 model precedes amyloid deposition
Van Dam, D., D'Hooge, R., Staufenbiel, M., Van Ginneken, C., Van Meir, F., & De Deyn, P. P. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02444.x · Cited by 296
Self-citationIntrathecal Chemokine Synthesis in Mild Cognitive Impairment and Alzheimer Disease
Galimberti, D., Schoonenboom, N., Scheltens, P., Fenoglio, C., Bouwman, F., Venturelli, E., Guidi, I., Blankenstein, M. A., Bresolin, N., & Scarpini, E. (2006) · Archives of Neurology · doi:10.1001/archneur.63.4.538 · Cited by 289
Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy
Winkler, D. T., Bondolfi, L., Herzig, M. C., Jann, L., Calhoun, M. E., Wiederhold, K.-H., Tolnay, M., Staufenbiel, M., & Jucker, M. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-05-01619.2001 · Cited by 287
Self-citationSchmitz, C., Rutten, B. P. F., Pielen, A., Schäfer, S., Wirths, O., Tremp, G., Czech, C., Blanchard, V., Multhaup, G., Rezaie, P., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63235-x · Cited by 281 · cited 1×
“The total number of neurons were obtained using unbiased stereology (Casas et al., 2004; Schmitz et al., 2004) and a microscope equipped with a digital camera (DEI-470; Optronics).”
MethodSenile Dementia of the Alzheimer Type Without Neocortical Neurofibrillary Tangles
TERRY, R. D., HANSEN, L. A., DETERESA, R., DAVIES, P., TOBIAS, H., & KATZMAN, R. (1987) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198705000-00003 · Cited by 268
Itoh, Y., Yamada, M., Hayakawa, M., Otomo, E., & Miyatake, T. (1993) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(93)90317-r · Cited by 262
Yang, L., Lindholm, K., Konishi, Y., Li, R., & Shen, Y. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03025.2002 · Cited by 256 · cited 2×
“TNFR1 signaling (Hsu et al., 1995; Yang et al., 2002).”
Self-citationInflammation and therapeutic vaccination in CNS diseases
Weiner, H. L., & Selkoe, D. J. (2002) · Nature · doi:10.1038/nature01325 · Cited by 255
Overexpression of type-1 adenylyl cyclase in mouse forebrain enhances recognition memory and LTP
Wang, H., Ferguson, G. D., Pineda, V. V., Cundiff, P. E., & Storm, D. R. (2004) · Nature Neuroscience · doi:10.1038/nn1248 · Cited by 244 · cited 1×
“Mice will spend more time exploring a novel object than a familiar one (Pittenger et al., 2002; Bourtchouladze et al., 2003; Wang et al., 2004).”
BackgroundWilcock, D. M., DiCarlo, G., Henderson, D., Jackson, J., Clarke, K., Ugen, K. E., Gordon, M. N., & Morgan, D. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03745.2003 · Cited by 232
Transcriptional Regulation of BACE1, the β-Amyloid Precursor Protein β-Secretase, by Sp1
Christensen, M. A., Zhou, W., Qing, H., Lehman, A., Philipsen, S., & Song, W. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.865-874.2004 · Cited by 221 · cited 2×
“To clarify how deletion of TNFR1 affects BACE1, we transfected 293 cells with a pB1P-A vector containing a BACE1 promoter (−1941 to +292) that was upstream of a luciferase reporter gene (Christensen et al., 2004; Sambamurti et al., 2004), and then treated these cells with different concentrations of TNFα.”
MethodA Second Look: “The Agenda for ‘Social Science History’”
Beach, W. W. (1980) · Social Science History · doi:10.1017/s0145553200018976 · Cited by 220
Gene structure and organization of the human β‐secretase ( BACE ) promoter
Sambamurti, K., Kinsey, R., Maloney, B., Ge, Y.-W., & Lahiri, D. K. (2004) · The FASEB Journal · doi:10.1096/fj.03-1378fje · Cited by 179 · cited 3×
“vicinity of BACE1 promoter (Sambamurti et al., 2004) suggests that NF-κB may play an important role in regulating BACE1 transcription.”
BackgroundMethodLi, R., Yang, L., Lindholm, K., Konishi, Y., Yue, X., Hampel, H., Zhang, D., & Shen, Y. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4580-03.2004 · Cited by 177 · cited 4×
“(Li et al., 2004b).”
BackgroundInfluentialSelf-citationShibata, N., Motoi, Y., Tomiyama, H., Ohnuma, T., Kuerban, B., Tomson, K., Komatsu, M., Shimazaki, H., Hattori, N., & Arai, H. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000351419 · Cited by 171
Shyu, W.-C., Lin, S.-Z., Chiang, M.-F., Su, C.-Y., & Li, H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5165-05.2006 · Cited by 169 · cited 1×
“, 1986) or von Willebrand factor (vWF; an endothelial cell marker; Shyu et al., 2006) and anti-Aβ40 antibody.”
BackgroundSaura, C. A., Chen, G., Malkani, S., Choi, S.-Y., Takahashi, R. H., Zhang, D., Gouras, G. K., Kirkwood, A., Morris, R. G. M., & Shen, J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1247-05.2005 · Cited by 157 · cited 1×
“by social recognition and spatial alternation tasks (Saura et al., 2005).”
BackgroundDiscovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation
Tobe, M., Isobe, Y., Tomizawa, H., Nagasaki, T., Takahashi, H., Fukazawa, T., & Hayashi, H. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(02)00440-6 · Cited by 151 · cited 2×
“After transfection, cells were treated with different concentrations of TNFα (R&D Systems), extracellular domain of TNFR1 (R&D Systems), or NF-κB inhibitor 6-amino-4(4-phenoxyphenylethylamino) quinazoline (Calbiochem; Tobe et al., 2003).”
MethodWiltfang, J., Smirnov, A., Schnierstein, B., Kelemen, G., Matthies, U., Klafki, H., Staufenbiel, M., Hüther, G., Rüther, E., & Kornhuber, J. (1997) · ELECTROPHORESIS · doi:10.1002/elps.1150180332 · Cited by 130 · cited 3×
“4 A shows a representative urea Western blot (Wiltfang et al., 1997) comparing the 4-kD Aβ species (n = 3 for each group).”
MethodResultInfluentialSelf-citationSubstrate Activation of Insulin-degrading Enzyme (Insulysin)
Song, E.-S., Juliano, M. A., Juliano, L., & Hersh, L. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308983200 · Cited by 121
Aging, Amyloid, and Alzheimer's Disease: A Perspective in Honor of Carl Cotman
Selkoe, D. J. (2003) · Neurochemical Research · doi:10.1023/a:1026065122854 · Cited by 110 · cited 1×
“Several lines of evidence implicate abnormal processing of APP, which is cleaved by two enzymes, β-secretase 1 (BACE1) and γ-secretase, to generate excessive amyloid β protein (Aβ), as a potential cause of AD (Selkoe, 2003; Tanzi and Bertram, 2005).”
BackgroundInterferon γ stimulates β-secretase expression and sAPPβ production in astrocytes
Hong, H. S., Hwang, E. M., Sim, H. J., Cho, H.-J., Boo, J. H., Oh, S. S., Kim, S. U., & Mook-Jung, I. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01270-1 · Cited by 81
Alzheimer disease without neocortical neurofibrillary tangles: “A second look”
Tiraboschi, P., Sabbagh, M. N., Hansen, L. A., Salmon, D. P., Merdes, A., Gamst, A. C., Masliah, E., Alford, M. F., Thal, L. J., & Corey‐Bloom, J. (2004) · Neurology · doi:10.1212/01.wnl.0000118212.41542.e7 · Cited by 68
Negative association between amyloid plaques and cerebral amyloid angiopathy in Alzheimer's disease
Tian, J., Shi, J., Bailey, K. L., & Mann, D. M. A. (2003) · Neuroscience Letters · doi:10.1016/j.neulet.2003.08.048 · Cited by 61
Pak, T. R., Cadet, P., Mantione, K. J., & Stefano, G. B. (2005) · PubMed · Cited by 43
[16] Neprilysin: Assay methods, purification, and characterization
Li, C., & Hersh, L. B. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(95)48018-8 · Cited by 40
Dooren, T. V., Muyllaert, D., Borghgraef, P., Cresens, A., Devijver, H., der Auwera, I. V., Wera, S., Dewachter, I., & LEUVEN, F. V. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050752 · Cited by 37
Zhou, J., Fonseca, M. I., Kayed, R., Hernandez, I., Webster, S. D., Yazan, O., Cribbs, D. H., Glabe, C. G., & Tenner, A. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-28 · Cited by 33
Thifault, S., Lalonde, R., Sanon, N., & Hamet, P. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(02)00782-7 · Cited by 29 · cited 1×
“JCB • VOLUME 178 • NUMBER 5 • 2007 834 mice with a hole-board memory test, which is a behavioral task widely used to assess exploratory learning and memory (Garcia, 1987; Thifault et al., 2002).”
MethodSerotonergic Neuronal Properties in C-Cell Lines
Clark, M. S., Lanigan, T. M., & Russo, A. F. (1995) · Methods · doi:10.1006/meth.1995.1030 · Cited by 28
Amyloid‐β Protein Angiopathies Masquerading as Alzheimer's Disease?a
COHEN, D. L., HEDERA, P., PREMKUMAR, D. R. D., FRIEDLAND, R. P., & KALARIA, R. N. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48490.x · Cited by 25
Cerebral Hemorrhage and Amyloid-β
Atwood, C., Perry, G. L., & Smith, M. A. (2003) · Science · doi:10.1126/science.299.5609.1014a · Cited by 24
A rotating holeboard procedure for testing drug effects on spatial learning and memory in mice
Brosnan-Watters, G., & Wozniak, D. F. (1997) · Brain Research Protocols · doi:10.1016/s1385-299x(97)00007-x · Cited by 17
Garcia, J. (1987) · Journal of Reproductive and Infant Psychology · doi:10.1080/02646838708403469 · Cited by 10 · cited 1×
“JCB • VOLUME 178 • NUMBER 5 • 2007 834 mice with a hole-board memory test, which is a behavioral task widely used to assess exploratory learning and memory (Garcia, 1987; Thifault et al., 2002).”
MethodSommer, B., & Staufenbiel, M. (1998) · Molecular Psychiatry · doi:10.1038/sj.mp.4000397 · Cited by 6 · cited 3×
“APP23 transgenic mice develop senile plaques in the cerebral cortex and hippocampus and show neuronal loss at 12–18 mo of age; this pathology is most evident in area CA1 of the hippocampus (Sommer and Staufenbiel, 1998).”
BackgroundInfluentialSelf-citationCorrections and Clarifications
(2003) · Science · doi:10.1126/science.299.5609.1014b · Cited by 2
Research works printed but not linked: 2
- 2003, Science., 299, 1014
- 2005, Med. Sci. Monit., 11, BR357
Cited by
Glutamate neurotoxicity and diseases of the nervous system
CHOI, D. (1988) · Neuron · doi:10.1016/0896-6273(88)90162-6 · Cited by 7,972
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498
Inflammation as a central mechanism in Alzheimer's disease
Kinney, J. W., Bemiller, S. M., Murtishaw, A. S., Leisgang, A. M., Salazar, A. M., & Lamb, B. T. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.06.014 · Cited by 2,253
Role of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Necroptosis and RIPK1-mediated neuroinflammation in CNS diseases
Yuan, J., Amin, P., & Ofengeim, D. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0093-1 · Cited by 967
Metadata
- Authors
- He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., & Shen, Y.
- Affiliations
- Banner Sun Health Research Institute (US)
- 1Haldeman Laboratory of Molecular and Cellular Neurobiology
- Brigham and Women's Hospital (US)
- Novartis (Switzerland) (CH)
- Corresponding author
- Shen, Yong
- Venue
- The Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2007-08-27
- Volume
- 178
- Issue
- 5
- Pages
- 829-841
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC2064547
- OpenAlex
- W2096277075
- Cited by
- 390
- References
- 76
- Citations by year
- 2026: 16 · 2025: 12 · 2024: 27 · 2023: 11 · 2022: 18 · 2021: 21 · 2020: 23 · 2019: 21 · 2018: 21 · 2017: 17 · 2016: 15 · 2015: 30 · 2014: 35 · 2013: 24 · 2012: 18
- FWCI
- 11.80
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (R01AG025888, AG025888)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- tumor necrosis factor receptor 1, Alzheimer's disease, amyloid-beta production, amyloid plaques, APP processing, beta-secretase 1, BACE1, NF-κB signaling, APP23 transgenic mice, learning and memory impairment, neurodegeneration, death receptor signaling
- MeSH terms
- Alzheimer Disease, Animals, Behavior, Animal, Disease Models, Animal, Gene Expression Regulation, Humans, Insulysin, Learning, Memory Disorders, Mice, Transgenic, Neurons, Promoter Regions, Genetic, Tumor Necrosis Factor-alpha, Neprilysin, Amyloid beta-Peptides, Aspartic Acid Endopeptidases, NF-kappa B, Cerebral Amyloid Angiopathy, Gene Deletion, Microglia, Mice, Knockout, Receptors, Tumor Necrosis Factor, Type I, Mice, Amyloid Precursor Protein Secretases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.